Issue 42, 2019, Issue in Progress

DFT study of the therapeutic potential of phosphorene as a new drug-delivery system to treat cancer

Abstract

In this study, the therapeutic potential of phosphorene as a drug-delivery system for chlorambucil to treat cancer was evaluated. The geometric, electronic and excited state properties of chlorambucil, phosphorene and the phosphorene–chlorambucil complex were evaluated to explore the efficiency of phosphorene as a drug-delivery system. The nature of interaction between phosphorene and chlorambucil is illustrated through a non-covalent interaction (NCI) plot, which illustrated that weak forces of interaction are present between phosphorene and chlorambucil. These weak intermolecular forces are advantageous for an easy offloading of the drug at the target. Frontier molecular orbital analysis revealed that charge was transferred from chlorambucil to phosphorene during excitation from the HOMO to LUMO. The charge transfer was further supplemented by charge-decomposition analysis (CDA). Excited-state calculations showed that the λmax was red-shifted by 79 nm for the phosphorene–chlorambucil complexes. The photo-induced electron-transfer (PET) process was observed for different excited states, which could be well explained visually based on the electron–hole theory. The photo-induced electron transfer suggests that a quenching of fluorescence occurs upon interaction. This study confirmed that phosphorene possesses significant therapeutic potential as a drug-delivery system for chlorambucil to treat cancer. This study will also motivate further exploration of other 2D materials for drug-delivery applications.

Graphical abstract: DFT study of the therapeutic potential of phosphorene as a new drug-delivery system to treat cancer

Article information

Article type
Paper
Submitted
12 Apr 2019
Accepted
14 Jul 2019
First published
06 Aug 2019
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2019,9, 24325-24332

DFT study of the therapeutic potential of phosphorene as a new drug-delivery system to treat cancer

A. Tariq, S. Nazir, A. W. Arshad, F. Nawaz, K. Ayub and J. Iqbal, RSC Adv., 2019, 9, 24325 DOI: 10.1039/C9RA02778E

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements